

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.55100615 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55100615 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.24931520 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24931520 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.96870079 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.80694184 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.61927487 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.19413585 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.15648230 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.15648230 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.15648230 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.02187304 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 5.96959739 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.94050169 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.79511549 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.71646220 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.71629113 |
| 18 | urea cycle (GO:0000050) | 5.68569167 |
| 19 | urea metabolic process (GO:0019627) | 5.68569167 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65036429 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.48219525 |
| 22 | * high-density lipoprotein particle remodeling (GO:0034375) | 5.47175536 |
| 23 | protein carboxylation (GO:0018214) | 5.42203014 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42203014 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.33744358 |
| 26 | cysteine metabolic process (GO:0006534) | 5.29112669 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.28133788 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.26206629 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.22860830 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.11120417 |
| 31 | bile acid metabolic process (GO:0008206) | 5.08704998 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 5.05047843 |
| 33 | reverse cholesterol transport (GO:0043691) | 5.04836868 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.01717834 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.95901454 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91929390 |
| 37 | regulation of complement activation (GO:0030449) | 4.89360653 |
| 38 | negative regulation of blood coagulation (GO:0030195) | 4.83294904 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.83294904 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.80862898 |
| 41 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.73846657 |
| 42 | * protein-lipid complex remodeling (GO:0034368) | 4.73846657 |
| 43 | * macromolecular complex remodeling (GO:0034367) | 4.73846657 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.71328290 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.71328290 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.69828950 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.63317241 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.62780233 |
| 49 | drug metabolic process (GO:0017144) | 4.60767262 |
| 50 | * regulation of cholesterol esterification (GO:0010872) | 4.56562046 |
| 51 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.56365675 |
| 52 | lysine catabolic process (GO:0006554) | 4.53202209 |
| 53 | lysine metabolic process (GO:0006553) | 4.53202209 |
| 54 | negative regulation of coagulation (GO:0050819) | 4.44735498 |
| 55 | * phospholipid efflux (GO:0033700) | 4.40842075 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.39215664 |
| 57 | glycine metabolic process (GO:0006544) | 4.38411830 |
| 58 | bile acid and bile salt transport (GO:0015721) | 4.36092912 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.35634458 |
| 60 | oxidative demethylation (GO:0070989) | 4.34952132 |
| 61 | positive regulation of blood coagulation (GO:0030194) | 4.34832968 |
| 62 | positive regulation of hemostasis (GO:1900048) | 4.34832968 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.34384051 |
| 64 | * negative regulation of cholesterol transport (GO:0032375) | 4.33667975 |
| 65 | * negative regulation of sterol transport (GO:0032372) | 4.33667975 |
| 66 | ethanol metabolic process (GO:0006067) | 4.31619435 |
| 67 | * plasma lipoprotein particle clearance (GO:0034381) | 4.30180455 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.28945932 |
| 69 | amine catabolic process (GO:0009310) | 4.28454097 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.28454097 |
| 71 | cellular glucuronidation (GO:0052695) | 4.25504000 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.25379118 |
| 73 | negative regulation of wound healing (GO:0061045) | 4.22770856 |
| 74 | phenylpropanoid metabolic process (GO:0009698) | 4.21477718 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.21366168 |
| 76 | glutamate metabolic process (GO:0006536) | 4.17072453 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17066817 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.14801610 |
| 79 | * cholesterol efflux (GO:0033344) | 4.14662997 |
| 80 | positive regulation of coagulation (GO:0050820) | 4.08669960 |
| 81 | fibrinolysis (GO:0042730) | 4.08528327 |
| 82 | * plasma lipoprotein particle organization (GO:0071827) | 4.05888624 |
| 83 | ethanol oxidation (GO:0006069) | 4.05080651 |
| 84 | arginine metabolic process (GO:0006525) | 4.03024138 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.01135750 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00058064 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.98947197 |
| 88 | drug catabolic process (GO:0042737) | 3.98912056 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.98021101 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.95991455 |
| 91 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.95713594 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92520509 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92520509 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86944783 |
| 95 | * protein-lipid complex subunit organization (GO:0071825) | 3.85305926 |
| 96 | regulation of humoral immune response (GO:0002920) | 3.85124157 |
| 97 | * plasma lipoprotein particle assembly (GO:0034377) | 3.82120701 |
| 98 | cofactor catabolic process (GO:0051187) | 3.82012629 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.80271160 |
| 100 | * protein-lipid complex assembly (GO:0065005) | 3.80190345 |
| 101 | ketone body metabolic process (GO:1902224) | 3.80018720 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.77341527 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.77341527 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.76185907 |
| 105 | heme transport (GO:0015886) | 3.75736262 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.74259667 |
| 107 | organic acid catabolic process (GO:0016054) | 3.74104575 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.74104575 |
| 109 | sterol homeostasis (GO:0055092) | 3.73773653 |
| 110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71964206 |
| 111 | regulation of apoptotic cell clearance (GO:2000425) | 3.71074357 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 3.71060385 |
| 113 | complement activation (GO:0006956) | 3.70499930 |
| 114 | protein activation cascade (GO:0072376) | 3.70426773 |
| 115 | negative regulation of protein activation cascade (GO:2000258) | 3.68797678 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66302999 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.65831098 |
| 118 | * negative regulation of lipase activity (GO:0060192) | 3.63307465 |
| 119 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62070967 |
| 120 | acute-phase response (GO:0006953) | 3.61441495 |
| 121 | opsonization (GO:0008228) | 3.61239581 |
| 122 | NAD biosynthetic process (GO:0009435) | 3.59921027 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.58471600 |
| 124 | cytolysis (GO:0019835) | 3.58300440 |
| 125 | S-adenosylmethionine metabolic process (GO:0046500) | 3.56736896 |
| 126 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56713787 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 3.54558062 |
| 128 | alkaloid metabolic process (GO:0009820) | 3.43560836 |
| 129 | * very-low-density lipoprotein particle assembly (GO:0034379) | 3.38999634 |
| 130 | * lipoprotein metabolic process (GO:0042157) | 3.36007144 |
| 131 | * negative regulation of lipid transport (GO:0032369) | 3.33731140 |
| 132 | steroid catabolic process (GO:0006706) | 3.32462752 |
| 133 | acute inflammatory response (GO:0002526) | 3.28272809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.35739804 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18876026 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.06747670 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48878577 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31230035 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19287351 |
| 7 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.96755014 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04443914 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03486707 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09352529 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06926634 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02203710 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9459433 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65923452 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60523114 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59925236 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57656711 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54163457 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45848781 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40123133 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39167045 |
| 22 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39132571 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34658866 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30437903 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27154169 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25015124 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23966486 |
| 28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19847583 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09964041 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09869935 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09125141 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03027643 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02219491 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99752908 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94021498 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92872210 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90125547 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89174707 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87108035 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86514865 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86169946 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83832279 |
| 43 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83577051 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83193674 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82794497 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82610703 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81897553 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80454494 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80043702 |
| 50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79131261 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78821931 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78300739 |
| 53 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77710972 |
| 54 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74392171 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74121079 |
| 56 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73905569 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73419576 |
| 58 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73221146 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71846250 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71230299 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70790748 |
| 62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70114060 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69578063 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.67690821 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67275112 |
| 66 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66579108 |
| 67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.66086951 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65594432 |
| 69 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65298131 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64181558 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64105101 |
| 72 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63765536 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63625586 |
| 74 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63563587 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.63556333 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63505608 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63505608 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62934332 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62425653 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62350649 |
| 81 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62301698 |
| 82 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.62083924 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61794423 |
| 84 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61742721 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61510592 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61056662 |
| 87 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.61021273 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.60621461 |
| 89 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.60078935 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59413480 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.58313416 |
| 92 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.57331906 |
| 93 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56924181 |
| 94 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56880032 |
| 95 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.56474317 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56236625 |
| 97 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.54578586 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53970478 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53541655 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52934235 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51188974 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50859620 |
| 103 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.50498786 |
| 104 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50123647 |
| 105 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49286580 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49242754 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48365275 |
| 108 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48086164 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47569489 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46719532 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46099602 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45269013 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43900090 |
| 114 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43787371 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43261646 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42087551 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41742313 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41644199 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41511840 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40816271 |
| 121 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40324653 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39533691 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.38911047 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37544729 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37456745 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37182586 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37153875 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35675484 |
| 129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35212706 |
| 130 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35041921 |
| 131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34939534 |
| 132 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34899937 |
| 133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.34847759 |
| 134 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.34482343 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34440244 |
| 136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34157465 |
| 137 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.33675543 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33400590 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33207671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.51514522 |
| 2 | MP0005360_urolithiasis | 7.48065018 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.16060531 |
| 4 | * MP0005365_abnormal_bile_salt | 5.98900254 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15276709 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.21000217 |
| 7 | MP0003252_abnormal_bile_duct | 3.88098800 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.65281002 |
| 9 | MP0009840_abnormal_foam_cell | 3.46574862 |
| 10 | MP0005083_abnormal_biliary_tract | 3.01543980 |
| 11 | MP0003195_calcinosis | 2.85060866 |
| 12 | MP0005332_abnormal_amino_acid | 2.75947275 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60838925 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.59007130 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.39542276 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.16082205 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.15107525 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.10486935 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.97351109 |
| 20 | MP0003868_abnormal_feces_composition | 1.85520408 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.81938497 |
| 22 | MP0001764_abnormal_homeostasis | 1.69664846 |
| 23 | MP0009697_abnormal_copulation | 1.66224626 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55716873 |
| 25 | MP0003011_delayed_dark_adaptation | 1.51076749 |
| 26 | MP0005451_abnormal_body_composition | 1.49153576 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.34188483 |
| 28 | MP0003186_abnormal_redox_activity | 1.30328664 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.24487803 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.19595788 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.16409852 |
| 32 | MP0000598_abnormal_liver_morphology | 1.16126278 |
| 33 | MP0005647_abnormal_sex_gland | 1.15969781 |
| 34 | MP0002254_reproductive_system_inflammat | 1.11301387 |
| 35 | MP0000604_amyloidosis | 1.09165473 |
| 36 | MP0009764_decreased_sensitivity_to | 1.06455734 |
| 37 | MP0009763_increased_sensitivity_to | 1.02717668 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.95216039 |
| 39 | MP0009785_altered_susceptibility_to | 0.93172738 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.91405038 |
| 41 | MP0008469_abnormal_protein_level | 0.89368476 |
| 42 | MP0002419_abnormal_innate_immunity | 0.87892770 |
| 43 | MP0005670_abnormal_white_adipose | 0.86675095 |
| 44 | * MP0009642_abnormal_blood_homeostasis | 0.86489297 |
| 45 | MP0001915_intracranial_hemorrhage | 0.86468792 |
| 46 | MP0000343_altered_response_to | 0.85324307 |
| 47 | MP0005408_hypopigmentation | 0.84762694 |
| 48 | MP0003879_abnormal_hair_cell | 0.84651163 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 0.82266780 |
| 50 | MP0005376_homeostasis/metabolism_phenot | 0.80511739 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 0.78343209 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.77061491 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.76944380 |
| 54 | MP0002971_abnormal_brown_adipose | 0.75398698 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.75279985 |
| 56 | MP0009053_abnormal_anal_canal | 0.72356514 |
| 57 | MP0003303_peritoneal_inflammation | 0.71797132 |
| 58 | MP0005334_abnormal_fat_pad | 0.71115747 |
| 59 | MP0004130_abnormal_muscle_cell | 0.70445703 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 0.69179001 |
| 61 | MP0003690_abnormal_glial_cell | 0.69173122 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 0.68347958 |
| 63 | MP0002090_abnormal_vision | 0.67667795 |
| 64 | MP0001661_extended_life_span | 0.66123153 |
| 65 | MP0000920_abnormal_myelination | 0.65658196 |
| 66 | MP0005535_abnormal_body_temperature | 0.65481934 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.64576468 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.64576468 |
| 69 | MP0003329_amyloid_beta_deposits | 0.64041545 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 0.63988088 |
| 71 | MP0005266_abnormal_metabolism | 0.63832503 |
| 72 | MP0005025_abnormal_response_to | 0.62807760 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.61202226 |
| 74 | MP0003632_abnormal_nervous_system | 0.60882523 |
| 75 | MP0001756_abnormal_urination | 0.59122195 |
| 76 | MP0005448_abnormal_energy_balance | 0.55327477 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.54601832 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.54406073 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 0.53580767 |
| 80 | MP0005464_abnormal_platelet_physiology | 0.53525984 |
| 81 | MP0000685_abnormal_immune_system | 0.53268851 |
| 82 | MP0005257_abnormal_intraocular_pressure | 0.51968865 |
| 83 | MP0002796_impaired_skin_barrier | 0.50747010 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.49931934 |
| 85 | MP0004381_abnormal_hair_follicle | 0.49843304 |
| 86 | MP0005023_abnormal_wound_healing | 0.49186476 |
| 87 | MP0005395_other_phenotype | 0.48998036 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.47900916 |
| 89 | MP0003718_maternal_effect | 0.47108100 |
| 90 | MP0000858_altered_metastatic_potential | 0.45980727 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.45770874 |
| 92 | MP0008874_decreased_physiological_sensi | 0.45559596 |
| 93 | MP0008873_increased_physiological_sensi | 0.45435819 |
| 94 | MP0002822_catalepsy | 0.44846584 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.43455837 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.43188705 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.42887583 |
| 98 | MP0003724_increased_susceptibility_to | 0.42872988 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.41608489 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.41393195 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.41338764 |
| 102 | MP0002928_abnormal_bile_duct | 0.41217586 |
| 103 | MP0003953_abnormal_hormone_level | 0.40607988 |
| 104 | MP0003436_decreased_susceptibility_to | 0.40333467 |
| 105 | MP0000579_abnormal_nail_morphology | 0.40041061 |
| 106 | MP0003075_altered_response_to | 0.39763700 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.37709837 |
| 108 | MP0005387_immune_system_phenotype | 0.37102438 |
| 109 | MP0001790_abnormal_immune_system | 0.37102438 |
| 110 | MP0008872_abnormal_physiological_respon | 0.36423694 |
| 111 | MP0009115_abnormal_fat_cell | 0.35785049 |
| 112 | MP0001243_abnormal_dermal_layer | 0.35662848 |
| 113 | MP0009672_abnormal_birth_weight | 0.35184994 |
| 114 | MP0005166_decreased_susceptibility_to | 0.34981486 |
| 115 | MP0002060_abnormal_skin_morphology | 0.33312741 |
| 116 | MP0001853_heart_inflammation | 0.33035430 |
| 117 | MP0001881_abnormal_mammary_gland | 0.32960666 |
| 118 | MP0004883_abnormal_blood_vessel | 0.32659093 |
| 119 | MP0002970_abnormal_white_adipose | 0.32476745 |
| 120 | MP0000249_abnormal_blood_vessel | 0.32358971 |
| 121 | MP0002168_other_aberrant_phenotype | 0.31423462 |
| 122 | MP0009384_cardiac_valve_regurgitation | 0.29961001 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.29477556 |
| 124 | MP0002132_abnormal_respiratory_system | 0.29462458 |
| 125 | MP0006082_CNS_inflammation | 0.28734473 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.27071675 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.26881434 |
| 128 | MP0005164_abnormal_response_to | 0.26774501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.41638376 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36556136 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.24129308 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75080382 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.60726344 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.58006841 |
| 7 | Xanthomatosis (HP:0000991) | 6.36896377 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.69767707 |
| 9 | Complement deficiency (HP:0004431) | 5.27654500 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.93052752 |
| 11 | Joint hemorrhage (HP:0005261) | 4.80727566 |
| 12 | Hyperammonemia (HP:0001987) | 4.62186363 |
| 13 | Epidermoid cyst (HP:0200040) | 4.56042652 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.51425283 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44352162 |
| 16 | Hyperglycinemia (HP:0002154) | 4.38622985 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.30600105 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.29108878 |
| 19 | Ketosis (HP:0001946) | 4.26425185 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21389464 |
| 21 | Fat malabsorption (HP:0002630) | 4.11513161 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09624398 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07640541 |
| 24 | Hypoglycemic coma (HP:0001325) | 4.00314815 |
| 25 | Hyperglycinuria (HP:0003108) | 3.93111208 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90003318 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.90003318 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.88323294 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.88323294 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.88323294 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87953416 |
| 32 | Abnormality of complement system (HP:0005339) | 3.85760505 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74297285 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.70497994 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66232625 |
| 36 | Purpura (HP:0000979) | 3.47804121 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38050864 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36972982 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.33522169 |
| 40 | Steatorrhea (HP:0002570) | 3.11705442 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.07709744 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06328702 |
| 43 | Ketoacidosis (HP:0001993) | 3.04930374 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.04850767 |
| 45 | Spontaneous abortion (HP:0005268) | 3.02638976 |
| 46 | Myocardial infarction (HP:0001658) | 2.93914325 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.92670517 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.90707215 |
| 49 | Skin nodule (HP:0200036) | 2.77727821 |
| 50 | Retinal atrophy (HP:0001105) | 2.75967437 |
| 51 | Metabolic acidosis (HP:0001942) | 2.74522408 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.72223516 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.67932306 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.65516346 |
| 55 | Lethargy (HP:0001254) | 2.64243279 |
| 56 | Vascular calcification (HP:0004934) | 2.62495894 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60963769 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.60963769 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.57763265 |
| 60 | Acanthocytosis (HP:0001927) | 2.51883063 |
| 61 | Increased serum ferritin (HP:0003281) | 2.51255022 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.50798803 |
| 63 | Cerebral edema (HP:0002181) | 2.49142484 |
| 64 | Glomerulonephritis (HP:0000099) | 2.45556718 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.45547973 |
| 66 | Spastic diplegia (HP:0001264) | 2.44076967 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.40873879 |
| 68 | Cholecystitis (HP:0001082) | 2.40873879 |
| 69 | Mitral stenosis (HP:0001718) | 2.40759274 |
| 70 | Amyloidosis (HP:0011034) | 2.40288466 |
| 71 | Cholelithiasis (HP:0001081) | 2.39567735 |
| 72 | Irritability (HP:0000737) | 2.35640571 |
| 73 | Neonatal onset (HP:0003623) | 2.32967681 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.32490314 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31766242 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.31766242 |
| 77 | Gout (HP:0001997) | 2.31436583 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30429907 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30429907 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30429907 |
| 81 | Pulmonary embolism (HP:0002204) | 2.28690453 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.28075753 |
| 83 | Gingival bleeding (HP:0000225) | 2.24542649 |
| 84 | Late onset (HP:0003584) | 2.23970692 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23749174 |
| 86 | Malnutrition (HP:0004395) | 2.23065080 |
| 87 | Esophageal varix (HP:0002040) | 2.18994993 |
| 88 | Brushfield spots (HP:0001088) | 2.18507654 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.16272784 |
| 90 | Menorrhagia (HP:0000132) | 2.14718839 |
| 91 | Pancreatitis (HP:0001733) | 2.14272460 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09938503 |
| 93 | Vomiting (HP:0002013) | 2.07753460 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.07155163 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.07150406 |
| 96 | Thrombophlebitis (HP:0004418) | 2.06072454 |
| 97 | Generalized aminoaciduria (HP:0002909) | 2.05459547 |
| 98 | Enlarged kidneys (HP:0000105) | 2.03973116 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.03310683 |
| 100 | Opisthotonus (HP:0002179) | 2.02743165 |
| 101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00851710 |
| 102 | Poikilocytosis (HP:0004447) | 1.99641311 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 1.98158648 |
| 104 | Hemorrhage of the eye (HP:0011885) | 1.98035683 |
| 105 | Reduced antithrombin III activity (HP:0001976) | 1.97784131 |
| 106 | Rickets (HP:0002748) | 1.94697092 |
| 107 | Osteomalacia (HP:0002749) | 1.93400920 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.90229050 |
| 109 | Cerebral inclusion bodies (HP:0100314) | 1.89326444 |
| 110 | Joint swelling (HP:0001386) | 1.87181508 |
| 111 | Renal cortical cysts (HP:0000803) | 1.86917412 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.85342037 |
| 113 | Gangrene (HP:0100758) | 1.83151072 |
| 114 | Nausea (HP:0002018) | 1.82545057 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.82208604 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.82208604 |
| 117 | Hyperglycemia (HP:0003074) | 1.81774646 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.80883912 |
| 119 | Elevated hepatic transaminases (HP:0002910) | 1.79003052 |
| 120 | Nephritis (HP:0000123) | 1.78559890 |
| 121 | Alkalosis (HP:0001948) | 1.78377879 |
| 122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77211363 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76295533 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.75687869 |
| 125 | Increased serum pyruvate (HP:0003542) | 1.74649191 |
| 126 | Epistaxis (HP:0000421) | 1.74418514 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.72762490 |
| 128 | Status epilepticus (HP:0002133) | 1.71340802 |
| 129 | Glycosuria (HP:0003076) | 1.69256408 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.69256408 |
| 131 | Polycythemia (HP:0001901) | 1.68147330 |
| 132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67646279 |
| 133 | Pathologic fracture (HP:0002756) | 1.64674482 |
| 134 | Mesangial abnormality (HP:0001966) | 1.62604235 |
| 135 | Abnormality of the periventricular white matter (HP:0002518) | 1.61991876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.26456399 |
| 2 | SIK1 | 4.61167767 |
| 3 | PDK2 | 4.58809525 |
| 4 | FGFR4 | 4.52000475 |
| 5 | ERN1 | 4.28080200 |
| 6 | NME2 | 3.24571917 |
| 7 | TAOK3 | 3.02824688 |
| 8 | INSRR | 2.88184580 |
| 9 | ERBB4 | 2.80526913 |
| 10 | MST1R | 2.39528075 |
| 11 | MAP2K4 | 2.24451834 |
| 12 | ACVR1B | 2.21774378 |
| 13 | BLK | 2.20788331 |
| 14 | PKN2 | 2.19211409 |
| 15 | PIK3CG | 2.01843716 |
| 16 | FLT3 | 1.92922491 |
| 17 | PRPF4B | 1.84493928 |
| 18 | MAPK11 | 1.84437518 |
| 19 | DAPK2 | 1.78780413 |
| 20 | TRIB3 | 1.78535901 |
| 21 | TYK2 | 1.70676718 |
| 22 | LATS1 | 1.67770005 |
| 23 | ABL2 | 1.50511169 |
| 24 | PTK6 | 1.45434013 |
| 25 | GRK7 | 1.45114906 |
| 26 | FGFR2 | 1.42454589 |
| 27 | MATK | 1.41300359 |
| 28 | FRK | 1.37781613 |
| 29 | NEK9 | 1.35701925 |
| 30 | PIM2 | 1.29254634 |
| 31 | KDR | 1.27788769 |
| 32 | JAK2 | 1.21373519 |
| 33 | CAMKK2 | 1.19571273 |
| 34 | DDR2 | 1.12671926 |
| 35 | ZAP70 | 1.12008427 |
| 36 | PRKAA2 | 1.10764160 |
| 37 | MAP3K7 | 1.10463185 |
| 38 | MAP3K3 | 1.10056417 |
| 39 | PINK1 | 1.09226995 |
| 40 | TBK1 | 1.07148439 |
| 41 | FGR | 1.05543763 |
| 42 | MAP2K3 | 1.05335330 |
| 43 | STK16 | 1.04164733 |
| 44 | TESK2 | 1.03933312 |
| 45 | MAP3K14 | 1.00485966 |
| 46 | GRK6 | 0.98993579 |
| 47 | MAPK4 | 0.98804988 |
| 48 | ERBB2 | 0.97648033 |
| 49 | JAK1 | 0.95839647 |
| 50 | MET | 0.95719778 |
| 51 | MAPK15 | 0.91126493 |
| 52 | PRKCZ | 0.91028649 |
| 53 | STK38L | 0.89284281 |
| 54 | MAP3K11 | 0.88769603 |
| 55 | MAP3K10 | 0.87335295 |
| 56 | CDK6 | 0.86082676 |
| 57 | NTRK3 | 0.85543237 |
| 58 | MAPK12 | 0.81439519 |
| 59 | EPHB1 | 0.79904791 |
| 60 | PRKACG | 0.77045496 |
| 61 | EPHA3 | 0.76282083 |
| 62 | CAMK1D | 0.75405000 |
| 63 | MAP3K2 | 0.75218679 |
| 64 | DYRK1B | 0.74986371 |
| 65 | MAP2K6 | 0.74461193 |
| 66 | CAMK2G | 0.73888960 |
| 67 | TIE1 | 0.73412357 |
| 68 | IKBKB | 0.73083393 |
| 69 | PAK4 | 0.71405283 |
| 70 | CSK | 0.68363492 |
| 71 | GSK3A | 0.66419891 |
| 72 | RIPK1 | 0.64917079 |
| 73 | PDGFRA | 0.61449567 |
| 74 | IRAK3 | 0.61098168 |
| 75 | PRKAA1 | 0.60261062 |
| 76 | TGFBR2 | 0.59636585 |
| 77 | CSNK2A1 | 0.59511554 |
| 78 | MAPK7 | 0.58438035 |
| 79 | ARAF | 0.58331831 |
| 80 | CAMK1G | 0.56825796 |
| 81 | IKBKE | 0.56383187 |
| 82 | CDC42BPA | 0.55546874 |
| 83 | JAK3 | 0.55349035 |
| 84 | FGFR3 | 0.54760373 |
| 85 | PTK2 | 0.53811881 |
| 86 | SGK3 | 0.53125739 |
| 87 | MAP2K1 | 0.52993864 |
| 88 | CSF1R | 0.52009838 |
| 89 | MAP3K12 | 0.51486434 |
| 90 | EPHA4 | 0.51302245 |
| 91 | SCYL2 | 0.51217950 |
| 92 | LYN | 0.51051173 |
| 93 | TAOK2 | 0.50783497 |
| 94 | PDPK1 | 0.50587350 |
| 95 | PRKG1 | 0.49569734 |
| 96 | GRK1 | 0.48608947 |
| 97 | PRKCQ | 0.48238542 |
| 98 | CSNK1G1 | 0.48104459 |
| 99 | IGF1R | 0.46083982 |
| 100 | MAPKAPK3 | 0.45834700 |
| 101 | RIPK4 | 0.45031952 |
| 102 | MAP3K5 | 0.42822430 |
| 103 | CDK4 | 0.42718662 |
| 104 | PRKACA | 0.42611294 |
| 105 | KSR2 | 0.41578934 |
| 106 | PRKACB | 0.41085602 |
| 107 | PBK | 0.40652616 |
| 108 | PRKG2 | 0.40012295 |
| 109 | PRKCG | 0.38290869 |
| 110 | SGK2 | 0.36780777 |
| 111 | MTOR | 0.36068785 |
| 112 | RET | 0.35561241 |
| 113 | PIK3CA | 0.35512899 |
| 114 | LRRK2 | 0.35330828 |
| 115 | EIF2AK1 | 0.35103373 |
| 116 | SRC | 0.33718170 |
| 117 | ICK | 0.33193445 |
| 118 | MAP3K6 | 0.32876001 |
| 119 | MAP3K13 | 0.32756633 |
| 120 | CSNK2A2 | 0.32706818 |
| 121 | PKN1 | 0.32668021 |
| 122 | EGFR | 0.32298315 |
| 123 | PRKCB | 0.32202475 |
| 124 | CAMK4 | 0.31365987 |
| 125 | PDK1 | 0.30875347 |
| 126 | MAP3K8 | 0.30600537 |
| 127 | LATS2 | 0.30493547 |
| 128 | DAPK3 | 0.28935071 |
| 129 | SGK1 | 0.28501014 |
| 130 | MAP2K2 | 0.27059390 |
| 131 | PRKCA | 0.27051286 |
| 132 | CSNK1G2 | 0.26623057 |
| 133 | CHUK | 0.26415930 |
| 134 | PDK3 | 0.26072589 |
| 135 | PDK4 | 0.26072589 |
| 136 | TESK1 | 0.25879653 |
| 137 | MAP3K1 | 0.25689405 |
| 138 | CSNK1G3 | 0.25648634 |
| 139 | EPHA2 | 0.24227046 |
| 140 | SGK494 | 0.24200827 |
| 141 | SGK223 | 0.24200827 |
| 142 | BMX | 0.21109466 |
| 143 | ABL1 | 0.20649635 |
| 144 | IRAK1 | 0.20516821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50669592 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49755917 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35639742 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32550346 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04743897 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74701897 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70551551 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67542931 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60856583 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53328000 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48398809 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38638731 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26419449 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24701238 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12234512 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09640575 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05160633 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03824563 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94049964 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91903112 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91141560 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90919839 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81992374 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78477412 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75607626 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75006099 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74015423 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71545812 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71273095 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67794448 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58804774 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56395282 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55373717 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51999047 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50589767 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46668277 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45450295 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37537188 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35378114 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33843384 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33026991 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31118152 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28155073 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24499437 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21458872 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19619774 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.19242403 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18068572 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13361356 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04759305 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02957252 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01021444 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97844305 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96408630 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94372456 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94027947 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.87815963 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87767374 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86296903 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79752005 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.78811036 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74366540 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73044827 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71574690 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.67523769 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67452960 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59772415 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56652813 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53481225 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49122134 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46213560 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.32478319 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.27732469 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26849359 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26763092 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25354991 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23790001 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.21683728 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21619014 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18105516 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17333875 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16068106 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14396967 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.13238631 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09143800 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08999851 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.04465994 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01887780 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2475632 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.2422779 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2422178 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2419314 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | -0.2282071 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2189214 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2147382 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1999078 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1932934 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1827249 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1680584 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1590972 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1561771 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1449465 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1387992 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1378988 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1281577 |
| 106 | Asthma_Homo sapiens_hsa05310 | -0.1054847 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1033807 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0973322 |
| 109 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0850546 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | -0.0802671 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0792009 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0460510 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0113433 |

